Global Tissue Adhesives Market Research Report by Type, by Application, by End User, and by Region Forecast till 2035

Description

List of Tables

Global Tissue Adhesives Market Research Report by Type [Synthetic & semi-Synthetic Adhesives (Cyanoacrylates, Polyethylene Glycol, Gelatin-Formaldehyde, Others), Natural Adhesives (Fibrin, Collagen, Dextran, Chitosan, Others)], by Application [Surgery (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Plastic & Reconstructive Surgery, Ophthalmic Surgery, Urological Surgery, Thoracic Surgery, Others), Wound Care, Burn Treatment], by End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers, Research Laboratories & Institutes), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035

Market Overview

The global tissue adhesives market is expected to reach USD 6.89 billion by 2035 at a CAGR of 9.06%. Tissue adhesives are medically specialized glues that are essentially beneficial for closing wounds in the skin. Moreover, by bonding to the tissue tightly and securely, they offer a less intrusion method of wound closure, thus generally leading to faster healing and better aesthetic results.

Innovation in bio-inspired, nanotechnology-enhanced, and polymer-based adhesives is transforming wound closure. These advancements improve bonding strength, cut closure times, and reduce infection risk, making tissue adhesives vital in modern minimally invasive surgeries. Enhanced delivery systems such as gels and sprays further accelerate adoption, positioning next-generation adhesives as a cornerstone of patient-centric, efficient, and sustainable surgical care worldwide.

Major Company Developments

B. Braun continues to strengthen its global footprint by emphasizing innovation, advanced technologies, and patient-centric healthcare solutions. The company invests heavily in R&D to develop next-generation products and improve existing ones, ensuring responsiveness to unmet medical needs. Its strategy revolves around four pillars-collaboration, cutting-edge integration, digital excellence, and customer alignment. In Hospital Care, the company is optimizing infusion pumps with integrated medication management systems. Aesculap focuses on expanding digital and robotic-assisted surgical solutions, while Avitum advances efficiency and connectivity in dialysis therapies. With ongoing refinement of chronic and acute treatment offerings, B. Braun is well-positioned to provide seamless, technology-driven solutions that enhance clinical efficiency, patient safety, and healthcare outcomes worldwide.

Key Players

Major players in the global tissue adhesives market are Meyer Haake GmbH, Essity, Zhejiang Perfectseal, Baxter, Chemence Medical, Inc., H.B. Fuller Medical Adhesive Technologies, LLC., Becton, Dickson and Company (BD), B. Braun, Artivion, GEM SRL, Advanced Medical Solutions (AMS), and Cohera Medical, Inc.

Report Attribute Details

Market Size 2024 USD 2,649.88 Million

Market Size 2035 USD 6,892.51 Million

CAGR (2025-2035) 9.06%

Base Year 2024

Market Forecast Period 2025-2035

Historical Data 2019, 2022, 2023

Market Segmentations (CAGR, 2025-2035)

By Type: Synthetic & Semi-Synthetic Adhesives - 8.30%, Natural Adhesives - 10.20%.

By Application: Surgery- 9.04%, Wound Care - 10.42%.

By End User: Hospitals and Specialty Clinics - 8.62%, Ambulatory Surgical Centers (ASCs) - 10.13%.

Regional Insights

North America is still the largest regional market by far, making up more than 40% of the total revenue share worldwide. The numerous cases of cardio-vascular, orthopedic, and reconstructive surgery have made tissue adhesives a must-have in modern surgical procedures. The U.S. dominates the North American tissue adhesives market with USD 913.72 million in 2024, while Canada follows with USD 199.90 million. The U.S. is still the most powerful country on the continent, primarily due to the large R&D investments and quick adoption of novel bio-based adhesives.

Europe demonstrates robust usage of tissue adhesives in specialized surgeries, where Germany, the UK, and France have been the major revenue centers. Germany is Europe's largest tissue adhesives market at USD 202.81 million in 2024, followed by the UK with USD 152.90 million and France with USD 127.60 million. The healthcare systems in Europe are focusing on shortened hospital stays and quicker recovery times, which is compatible with the effectiveness provided by tissue adhesives.

The drive behind the fast growth of the Asia-Pacific market is the huge volume of surgical procedures required and the increasing recognition of non-invasive wound closure methods. China tops the APAC tissue adhesives market with USD 134.08 million in 2024, followed by Japan at USD 112.07 million and India at USD 98.85 million. These countries dominate regional demand, fueled by expanding healthcare access and surgical procedures. China and India's markets are expanding rapidly due to a surge in trauma cases and rising investments in both private and public hospitals, supported by the government-backed initiatives to localize production of surgical consumables.

The Rest of the World market is growing steadily, led by Brazil's rise in cosmetic surgeries, Gulf states' investments in advanced healthcare, and gradual adoption in Africa, supported by global healthcare partnerships despite access and cost challenges.

Product Code: MRFR/HC/57881-CR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING SURGICAL PROCEDURES
- 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN TISSUE ADHESIVE PRODUCTS
- 4.2.3 AGING POPULATION ACROSS THE GLOBE
4.3 RESTRAINTS
- 4.3.1 HIGH COST OF ADVANCED TISSUE ADHESIVES
- 4.3.2 RISK OF ADHESIVE FAILURE
- 4.3.3 REGULATORY HURDLES
4.4 OPPORTUNITY
- 4.4.1 INCREASING DEMAND FOR ENVIRONMENTAL AND BIODEGRADABLE ADHESIVES
- 4.4.2 EXPANSION IN SURGICAL APPLICATIONS
- 4.4.3 FOCUS ON PATIENT-CENTRIC PRODUCTS

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON GLOBAL TISSUE ADHESIVES MARKET

6 GLOBAL TISSUE ADHESIVES MARKET, BY TYPE

6.1 OVERVIEW
6.2 SYNTHETIC & SEMI-SYNTHETIC ADHESIVES
- 6.2.1 CYANOACRYLATES
- 6.2.2 POLYETHYLENE GLYCOL
- 6.2.3 GELATIN-FORMALDEHYDE
- 6.2.4 OTHERS
6.3 NATURAL ADHESIVES
- 6.3.1 FIBRIN
- 6.3.2 COLLAGEN
- 6.3.3 DEXTRAN
- 6.3.4 CHITOSAN
- 6.3.5 OTHERS

7 GLOBAL TISSUE ADHESIVES MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 SURGERY
- 7.2.1 CARDIOVASCULAR SURGERY
- 7.2.2 ORTHOPEDIC SURGERY
- 7.2.3 GENERAL SURGERY
- 7.2.4 NEUROSURGERY
- 7.2.5 PLASTIC & RECONSTRUCTIVE SURGERY
- 7.2.6 OPHTHALMIC SURGERY
- 7.2.7 UROLOGICAL SURGERY
- 7.2.8 THORACIC SURGERY
- 7.2.9 OTHERS
7.3 WOUND CARE
7.4 BURN TREATMENT

8 GLOBAL TISSUE ADHESIVES MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS AND SPECIALTY CLINICS
8.3 AMBULATORY SURGICAL CENTERS (ASCS)
8.4 RESEARCH LABORATORIES & INSTITUTES

9 GLOBAL TISSUE ADHESIVES MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 AUSTRALIA
- 9.4.5 SOUTH KOREA
- 9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST AND AFRICA
- 9.5.2 SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2024
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL

11 COMPANY PROFILES

11.1 MEYER-HAAKE GMBH
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 KEY STRATEGIES
11.2 ESSITY
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 KEY STRATEGY
11.3 ZHEJIANG PERFECTSEAL
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 KEY STRATEGIES
11.4 BAXTER
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
11.5 CHEMENCE MEDICAL, INC.
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 H.B. FULLER MEDICAL ADHESIVE TECHNOLOGIES, LLC
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 BECTON, DICKINSON AND COMPANY
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 B. BRAUN SE
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 ARTIVION
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 SWOT ANALYSIS
- 11.9.6 KEY STRATEGIES
11.10 GEM SRL
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCT OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES
11.11 ADVANCED MEDICAL SOLUTIONS
- 11.11.1 COMPANY OVERVIEW
- 11.11.2 FINANCIAL OVERVIEW
- 11.11.3 PRODUCTS OFFERED
- 11.11.4 KEY DEVELOPMENTS
- 11.11.5 KEY STRATEGIES
11.12 COHERA MEDICAL, INC.
- 11.12.1 COMPANY OVERVIEW
- 11.12.2 FINANCIAL OVERVIEW
- 11.12.3 PRODUCTS OFFERED
- 11.12.4 KEY DEVELOPMENTS
- 11.12.5 KEY STRATEGIES

12 DATA CITATIONS